BIOTRONIK Showcases DX System at Premier Healthcare Alliance’s 2013 Breakthroughs Conference and Exhibition

The BIOTRONIK DX System, a first-in-class implantable cardiac defibrillator (ICD) providing dual-chamber diagnostic capabilities with a single lead, was one of 14 medical innovations on display in front of thousands of healthcare providers and experts at the Premier healthcare alliance’s 2013 Breakthroughs Conference and Exhibition. It showcased during the conference’s fifth annual Innovation Celebration, which took place on June 11 in San Antonio, Texas. The event recognizes advances in healthcare while highlighting industry suppliers committed to innovation and improving patient outcomes.

BIOTRONIK’s DX System was selected for display by clinicians and other members of Premier, a provider-owned performance improvement alliance of more than 2,800 hospitals and nearly 100,000 other care sites, on the basis of strenuous selection criteria. These included the uniqueness of the product, its ability to have an impact on an unmet medical need and its potential to improve patient care.

The DX System – comprised of the Lumax 740 VR-T DX or the recently FDA-approved Ilesto 7 VR-T DX, and Linox^smart S DX lead – offers the unique benefits of both single and dual-chamber ICDs. In addition to providing a powerful technology in the fight against heart disease, the DX System solves the controversial issue of device selection. The use of dual-chamber devices in patients without a clear indication for the use of an additional atrial lead has received a great deal of attention over the past few years. The DX System virtually eliminates this issue, representing a new paradigm in ICD therapy that fills a critical clinical need.

“We’re incredibly honored to be recognized at Premier’s Innovation Celebration for a system that has been years in the making,” said Rex Richmond, vice president of marketing and communications at BIOTRONIK, Inc. “Since receiving FDA approval this past February, demand for the DX System has exceeded our expectations. Patients and physicians across the United States now have the benefits of a single-chamber, single-lead ICD with the full atrial diagnostic capabilities of a dual-chamber device – but with far less hardware.”

“Those who attend and participate in the Innovation Celebration share Premier’s commitment to providing innovative, valuable products to our members that are safe, high-quality and cost-effective,” said Durral R. Gilbert, president of supply chain services, Premier. “These advancements will truly benefit providers as they work to improve the health of their communities.”

About the Premier healthcare alliance, Malcolm Baldrige National Quality Award recipient
Premier is the nation’s largest performance improvement alliance of more than 2,800 U.S. hospitals and nearly 100,000 other sites using the power of collaboration and technology to lead the transformation to coordinated, high-quality, cost-effective care. Owned by healthcare providers, Premier operates a leading purchasing network with more than $5 billion in annual savings. Premier also maintains clinical, financial and outcomes databases based on 1 in every 4 patient discharges. A world leader in measurably improving patient care, Premier has the largest performance improvement collaboratives in America, including one in partnership with the Centers for Medicare & Medicaid Services. Headquartered in Charlotte, N.C., Premier also has an office in Washington. https://www.premierinc.com. Stay connected with Premier on Facebook, Twitter, LinkedInand YouTube.

About BIOTRONIK SE & Co. KG
As one of the world’s leading manufacturers of cardiovascular medical devices, BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries by its global workforce of more than 5,600 employees. Several million heart patients around the world have received BIOTRONIK implants, designed to save and improve the quality of their lives. Since its development of the first German pacemaker in 1963, BIOTRONIK has launched several innovations into the market – including remote monitoring with BIOTRONIK Home Monitoring^® in 2000 and the world’s first implantable cardioverter-defibrillators and implantable heart failure therapy devices with ProMRI^® technology, approved for MR scanning, in 2012. This year, BIOTRONIK is celebrating its 50th anniversary.

For more information, visit: www.biotronik.com